The clear need for real-time, direct visualization to guide transesophageal echocardiogram (TEE) intubations continues to drive adoption of Visura's digital camera system, TEECAD, at US heart centers MINNEAPOLIS , Oct. 24, 2024 /PRNewswire/ -- Visura Technologies , Inc., a privately-held medical device company dedicated to delivering state-of-the-art visualization solutions to improve the safety and success of TEE probe intubations, announced today the accomplishment of several key commercial milestones in Q3 driving strong growth of the TEECAD system and the interest of partners.
The milestones achieved include: Presentation of data from four cardiologists at Mayo Clinic in Rochester, MN to the American College of Cardiology's annual meeting; The introduction of new multi-hospital data, sharing the positive outcomes in over 100 patients, including ability to navigate to esophageal outlet in 96.3% of patients and no adverse events; Record sales in Q3 with a record sales month in September; and The first TEECAD installation at a Veterans Administration (VA) hospital at Jesse Brown VA in Chicago, IL. On the heels of this strong business momentum, Visura recently announced the successful completion of a multi-million dollar bridge round of financing to support its expanded commercial activities.
Chad Olinger D .O, Cardiologist at Metropolitan Heart and Vascular Institute in Minneapolis, MN and Visura's new Medical Director stated, "I've definitely had cases where I thought to my.